Skip to main content
SpringerLink
Log in

Deep brain stimulation for treatment-resistant depression: A psychiatric perspective

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Traditionally, the therapeutic approach to treatmentresistant depression (TRD) has relied on pharmacotherapy in various sequences and combinations, in addition to evidence-based psychotherapy or electroconvulsive therapy. Despite refinements to the existing therapeutic modalities, there remains a significant subpopulation of severely ill patients with refractory mood disorders who fail to achieve a clinical response despite aggressive psychosocial and biological treatments. Interest in the use of deep brain stimulation (DBS) for treatment-resistant psychiatric illness has emerged in recent years for a number of reasons: 1) as part of a general re-evaluation of both noninvasive and invasive brain stimulation techniques, 2) because of the demonstrated clinical efficacy of DBS for movement disorders, and 3) as a logical consequence of studies defining the functional neurocircuitry of several psychiatric disorders. This review will examine the progress of DBS in the treatment of Parkinson’s disease and the potential implications for its use in TRD, as well as the role of the psychiatrist in selection and ongoing management of patients who receive this procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pool JL, Clark WD, Hudson P, Lombardo M: Hypothalamic-Hypophysial Interrelationships. Springfield, IL: Charles C. Thomas; 1956.

    Google Scholar 

  2. Hosobuchi Y, Adams JE, Rutkin B: Chronic thalamic and internal capsule stimulation for the control of central pain. Surg Neurol 1975, 4:91–92.

    PubMed  CAS  Google Scholar 

  3. Deep-Brain Stimulation for Parkinson’s Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001, 345:956–963.

    Article  Google Scholar 

  4. Lozano AM: Vim thalamic stimulation for tremor. Arch Med Res 2000, 31:266–269.

    Article  PubMed  CAS  Google Scholar 

  5. Anderson WS, Lenz FA: Surgery insight: deep brain stimulation for movement disorders. Nat Clin Pract Neurol 2006, 2:310–320. Excellent contemporary summary of neurobiological basis of DBS and its clinical efficacy in treating individuals with movement disorders.

    Article  PubMed  Google Scholar 

  6. Kleiner-Fisman G, Fisman DN, Sime E, et al.: Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003, 99:489–495.

    PubMed  Google Scholar 

  7. Lang AE, Widner H: Deep brain stimulation for Parkinson’s disease: patient selection and evaluation. Mov Disord 2002, 17(Suppl 3):S94-S101.

    Article  PubMed  Google Scholar 

  8. Benabid AL, Chabardes S, Seigneuret E: Deep-brain stimulation in Parkinson’s disease: long-term efficacy and safety-What happened this year? Curr Opin Neurol 2005, 18:623–630.

    Article  PubMed  Google Scholar 

  9. Lozano AM, Mahant N: Deep brain stimulation surgery for Parkinson’s disease: mechanisms and consequences. Parkinsonism Relat Disord 2004, 10(Suppl 1):S49-S57.

    Article  PubMed  Google Scholar 

  10. Kleiner-Fisman G, Herzog J, Fisman DN, et al.: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006, 21(Suppl 14):S290-S304. Review and meta-analysis of the experience of STN DBS in PD.

    Article  PubMed  Google Scholar 

  11. Visser-Vandewalle V, Ackermans L, van der Linden C, et al.: Deep brain stimulation in Gilles de la Tourette’s syndrome. Neurosurgery 2006, 58:E590.

    PubMed  Google Scholar 

  12. Benabid AL: Deep brain stimulation for Parkinson’s disease. Curr Opin Neurobiol 2003, 13:696–706.

    Article  PubMed  CAS  Google Scholar 

  13. Bin-Mahfoodh M, Hamani C, Sime E, Lozano AM: Longevity of batteries in internal pulse generators used for deep brain stimulation. Stereotact Funct Neurosurg 2003, 80:56–60.

    Article  PubMed  Google Scholar 

  14. Moro E, Poon YY, Lozano AM, et al.: Subthalamic nucleus stimulation: improvements in outcome with reprogramming. Arch Neurol 2006, 63:1266–1272. Recent article demonstrating the optimization of long-term outcomes with DBS through medication management and DBS programming by multidiscliplinary teams skilled in the management of PD.

    Article  PubMed  Google Scholar 

  15. McIntyre CC, Savasta M, Walter BL, Vitek JL: How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 2004, 21:40 -50. Excellent article about the putative neurobiological mechanisms of DBS accessible to the psychiatrist.

    Article  PubMed  Google Scholar 

  16. Volkmann J, Moro E, Pahwa R: Basic algorithms for the programming of deep brain stimulation in Parkinson’s Disease. Mov Disord 2006, 21(Suppl 14):S284-S289. Algorithms for DBS parameters derived from work in PD.

    Article  PubMed  Google Scholar 

  17. Krack P, Batir A, Van Blercom N, et al.: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003, 349:1925–1934.

    Article  PubMed  CAS  Google Scholar 

  18. Deuschl G, Herzog J, Kleiner-Fisman G, et al.: Deep brain stimulation: postoperative issues. Mov Disord 2006, 21(Suppl 14):S219-S237.

    Article  PubMed  Google Scholar 

  19. Benabid AL, Pollak P, Louveau A, et al.: Combined (thalamotomy, stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson’s disease. Appl Neurophysiol 1987, 50:344–346.

    Article  PubMed  CAS  Google Scholar 

  20. Benabid AL, Pollak P, Gervason C, et al.: Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991, 337:403–406.

    Article  PubMed  CAS  Google Scholar 

  21. Beurrier C, Bioulac B, Audin J, Hammond C: High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 2001, 85:1351–1356.

    PubMed  CAS  Google Scholar 

  22. Dostrovsky JO, Levy R, Wu JP, et al.: Microstimulationinduced inhibition of neuronal firing in human globus pallidus. J Neurophysiol 2000, 84:570–574.

    PubMed  CAS  Google Scholar 

  23. Urbano FJ, Leznik E, Llinas RR: Cortical activation patterns evoked by afferent axons stimuli at different frequencies: an in vitro voltage sensitive dye imaging study. Thalamus Rel Syst 2002, 1:371–378.

    Google Scholar 

  24. Montgomery EB, Baker KB: Mechanisms of deep brain stimulation and future technical developments. Neurol Res 2000, 22:259–266.

    PubMed  Google Scholar 

  25. Dostrovsky JO, Lozano AM: Mechanisms of deep brain stimulation. Mov Disord 2002, 17(Suppl 3):S63-S68.

    Article  PubMed  Google Scholar 

  26. Perlmutter JS, Mink JW: Deep brain stimulation. Annu Rev Neurosci 2006, 29:229–257. Review of the current state of DBS for neuropsychiatric disorders and future vistas.

    Article  PubMed  CAS  Google Scholar 

  27. Greden JF: The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001, 62(Suppl 16):26–31.

    PubMed  Google Scholar 

  28. Keller MB: Issues in treatment-resistant depression. J Clin Psychiatry 2005, 66(Suppl 8):5–12.

    PubMed  CAS  Google Scholar 

  29. Trivedi MH, Fava M, Wisniewski SR, et al.: Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006, 354:1243–1252.

    Article  PubMed  CAS  Google Scholar 

  30. Rush AJ, Trivedi MH, Wisniewski SR, et al.: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006, 354:1231–1242.

    Article  PubMed  CAS  Google Scholar 

  31. Fava M, Rush AJ, Wisniewski SR, et al.: A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 2006, 163:1161–1172.

    Article  PubMed  Google Scholar 

  32. Berton O, Nestler EJ: New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137–151. Article exploring the limitations of the monoamine hypothesis of depression that also reviews novel therapeutic targets, including corticotropin-releasing factor antagonists and peptidergic and neurotrophic agents.

    Article  PubMed  CAS  Google Scholar 

  33. Mayberg HS: Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003, 65:193–207. Summary of the hypothesis of dysregulated cortical-limbic neurocircuitry in depression.

    Article  PubMed  Google Scholar 

  34. Milak MS, Parsey RV, Keilp J, et al.: Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005, 62:397–408.

    Article  PubMed  Google Scholar 

  35. Rauch SL: Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg Clin N Am 2003, 14:213–223. Review of neurocircuitry models of depression and OCD, integrating data from neuroimaging, as well as ablative psychosurgical techniques.

    Article  PubMed  Google Scholar 

  36. Drevets WC, Raichle ME: Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992, 28:261–274.

    PubMed  CAS  Google Scholar 

  37. Mayberg HS: De.ning neurocircuits in depression: strategies toward treatment selection based on neuroimaging phenotypes. Psychiatr Ann 2006, 36:259–268. Integrative review of neuroimaging findings from psychotherapeutic, pharmacologic, and surgical interventions for depression in the context of the neurocircuitry hypothesis of depression.

    Google Scholar 

  38. Mayberg HS, Lozano AM, Voon V, et al.: Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651–660. First report of the use of DBS in BA25 for TRD.

    Article  PubMed  CAS  Google Scholar 

  39. Mayberg HS, Lozano AM, Voon V, et al.: Sustained response to chronic deep brain stimulation (DBS) of the subgenual cingulate region (Cg25) in treatment resistant depression: 1 year follow-up. Paper presented at the Annual Meeting of the Society for Neuroscience. Washington, DC; November 12–16, 2005.

  40. Kennedy SH, Fulton KA, Giacobbe P, et al.: Predictors of response to deep brain stimulation for treatment resistant depression. Paper presented at the Annual Meeting of the American Psychiatric Association. Toronto, Ontario; May 20–25, 2006.

  41. Greenberg BD, Malone DA, Friehs GM, et al.: Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006, In press. Recently published results of an ongoing longitudinal study of DBS for refractory OCD.

  42. Gabriels L, Cosyns P, Nuttin B, et al.: Deep brain stimulation for treatment refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand 2003, 107:275–282.

    Article  PubMed  CAS  Google Scholar 

  43. Abelson JL, Curtis GC, Sagher O, et al.: Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 2005, 57:510–516.

    Article  PubMed  Google Scholar 

  44. Flaherty AW, Williams ZM, Amirnovin R, et al.: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005, 57(4 Suppl 4):E403.

    Article  PubMed  Google Scholar 

  45. Van Laere K, Nuttin B, Gabriels L, et al.: Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 2006, 47:740 -747. Recent article demonstrating that the stimulation of the anterior limb of the internal capsule for OCD may produce changes in the metabolic activity of the subgenual ACC. This finding provides evidence that stimulating at various locations within the corticallimbic neurocircuitry may produce similar neurobiological changes associated with treatment response.

    PubMed  Google Scholar 

  46. Sturm V, Lenartz D, Koulousakis A, et al.: The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat 2003, 26:293–299.

    Article  PubMed  Google Scholar 

  47. Schlaepfer TE, Lieb K: Deep brain stimulation for treatment of refractory depression. Lancet 2005, 366:1420–1422.

    Article  PubMed  Google Scholar 

  48. Nestler EJ, Barrot M, DiLeone RJ, et al.: Neurobiology of depression. Neuron 2002, 34:13–25.

    Article  PubMed  CAS  Google Scholar 

  49. Nestler EJ, Carlezon WA, Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59:1151–1159. Review of the role of dopamine in reward circuits, supporting the rationale for stimulation of the nucleus accumbens in TRD.

    Article  PubMed  CAS  Google Scholar 

  50. Aouizerate B, Cuny E, Martin-Guehl C, et al.: Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004, 101:682–686.

    Article  PubMed  Google Scholar 

  51. Aouizerate B, Martin-Guehl C, Cuny E, et al.: Deep brain stimulation for OCD and major depression. Am J Psychiatry 2005, 162:2192. First case report of the effectiveness of DBS in the caudate nucleus for an individual with depression and comorbid OCD.

    Article  PubMed  Google Scholar 

  52. Jimenez F, Velasco F, Salin-Pascual R: A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005, 57:585–593.

    Article  PubMed  Google Scholar 

  53. Velasco F, Velasco M, Jimenez F, et al.: Neurobiological background for performing surgical intervention in the inferior thalamic peduncle for treatment of major depression disorders. Neurosurgery 2005, 57:439–448.

    Article  PubMed  Google Scholar 

  54. Nuttin BJ, Gabriels L, van Kuyck K, Cosyns P: Electrical stimulation of the anterior limbs of the internal capsule in patients with severe obsessive-compulsive disorder: anecdotal reports. Neurosurg Clin N Am 2003, 14:267–274.

    Article  PubMed  Google Scholar 

  55. Wester K, Hauglie-Hanssen E: The prognostic value of intraoperative observations during thalamotomy for parkinsonian tremor. Clin Neurol Neurosurg 1992, 94:25–30.

    Article  PubMed  CAS  Google Scholar 

  56. Benabid AL, Koudsie A, Benazzouz A, et al.: Subthalamic stimulation for PD. Arch Med Res 2000, 31:282–289.

    Article  PubMed  CAS  Google Scholar 

  57. Lozano AM, Hamani C: The future of deep brain stimulation. J Clin Neurophysiol 2004, 21:68–69.

    Article  PubMed  Google Scholar 

  58. Jenike MA: Clinical practice. Obsessive-compulsive disorder. N Engl J Med 2004, 350:259–265.

    Article  PubMed  CAS  Google Scholar 

  59. Dougherty DD, Rauch SL, Jenike MA: Pharmacotherapy for obsessive-compulsive disorder. J Clin Psychol 2004, 60:1195–1202.

    Article  PubMed  Google Scholar 

  60. Miyasaki JM, Shannon K, Voon V, et al.: Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 66:996–1002.

    Article  PubMed  CAS  Google Scholar 

  61. Kennedy SH, Lam RW, Cohen NL, et al.: Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001, 46(Suppl 1):38S-58S.

    PubMed  Google Scholar 

  62. Burkhard PR, Vingerhoets FJ, Berney A, et al.: Suicide after successful deep brain stimulation for movement disorders. Neurology 2004, 63:2170–2172.

    PubMed  CAS  Google Scholar 

  63. Foncke EM, Schuurman PR, Speelman JD: Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 2006, 66:142–143.

    Article  PubMed  CAS  Google Scholar 

  64. Chou KL, Hurtig HI, Jaggi JL, et al.: Electroconvulsive therapy for depression in a PD patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism Relat Disord 2005, 11:403–406.

    Article  PubMed  Google Scholar 

  65. Kopell BH, Greenberg B, Rezai AR: Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol 2004, 21:51–67. Excellent synopsis of the progression of neurosurgical techniques for psychiatric illness, limitations, and ethical issues associated with existing neurosurgical treatments, and the promise of DBS.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Health Network, 200 Elizabeth Street, EN8-222, M5G 2C4, Toronto, Ontario, Canada

    Sidney H. Kennedy MD, FRCP(C)

Authors
  1. Peter Giacobbe MD, FRCP(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sidney H. Kennedy MD, FRCP(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sidney H. Kennedy MD, FRCP(C).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giacobbe, P., Kennedy, S.H. Deep brain stimulation for treatment-resistant depression: A psychiatric perspective. Curr Psychiatry Rep 8, 437–444 (2006). https://doi.org/10.1007/s11920-006-0048-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-006-0048-5

Keywords

Search

Navigation